📰 Lpcn News
Lpcn News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Lpcn. Real-time updates on events, politics, business and more.
April 28, 2024
StockNews.com initiated coverage on shares of Lipocine (NASDAQ:LPCN – Free Report) in a research report released on Saturday morning. The brokerage issued a sell rating on the specialty pharmaceutical company’s stock. Lipocine Stock Performance LPCN opened at $4.80 on Friday. Lipocine has a fifty-two week low of $2.31 and a fifty-two week high of $7.15. […]
March 29, 2024
StockNews.com assumed coverage on shares of Lipocine (NASDAQ:LPCN – Free Report) in a report published on Tuesday. The firm issued a sell rating on the specialty pharmaceutical company’s stock. Lipocine Stock Performance Shares of LPCN stock opened at $5.20 on Tuesday. The stock’s 50 day simple moving average is $4.04 and its 200 day simple […]
February 19, 2024
StockNews.com started coverage on shares of Lipocine (NASDAQ:LPCN – Free Report) in a research report sent to investors on Thursday morning. The firm issued a sell rating on the specialty pharmaceutical company’s stock. Lipocine Price Performance Shares of Lipocine stock opened at $4.01 on Thursday. Lipocine has a fifty-two week low of $2.31 and a […]
February 2, 2024
StockNews.com assumed coverage on shares of Lipocine (NASDAQ:LPCN – Free Report) in a report published on Tuesday. The firm issued a sell rating on the specialty pharmaceutical company’s stock. Lipocine Trading Up 2.1 % Shares of NASDAQ:LPCN opened at $3.98 on Tuesday. The stock has a fifty day simple moving average of $3.07 and a […]
January 26, 2024
StockNews.com began coverage on shares of Lipocine (NASDAQ:LPCN – Free Report) in a research note issued to investors on Monday. The brokerage issued a sell rating on the specialty pharmaceutical company’s stock. Lipocine Stock Performance Shares of NASDAQ:LPCN opened at $3.83 on Monday. Lipocine has a fifty-two week low of $2.31 and a fifty-two week […]
January 18, 2024
StockNews.com initiated coverage on shares of Lipocine (NASDAQ:LPCN – Free Report) in a research note published on Sunday morning. The firm issued a sell rating on the specialty pharmaceutical company’s stock. Lipocine Stock Down 6.3 % Shares of Lipocine stock opened at $3.85 on Friday. The company has a market capitalization of $20.47 million, a […]
January 18, 2024
By Colin Kellaher Shares of Lipocine moved higher in premarket trading Thursday after the biopharmaceutical company said it struck a potentially lucrative...
December 9, 2023
StockNews.com initiated coverage on shares of Lipocine (NASDAQ:LPCN – Free Report) in a research note published on Tuesday morning. The firm issued a sell rating on the specialty pharmaceutical company’s stock. Lipocine Trading Down 1.5 % NASDAQ:LPCN opened at $2.56 on Tuesday. Lipocine has a 12 month low of $2.31 and a 12 month high […]
December 6, 2023
Lipocine Inc. (NASDAQ:LPCN – Get Free Report) shares passed above its 50 day moving average during trading on Monday . The stock has a 50 day moving average of $2.64 and traded as high as $2.73. Lipocine shares last traded at $2.73, with a volume of 9,265 shares. Analysts Set New Price Targets Separately, StockNews.com […]
December 1, 2023
StockNews.com assumed coverage on shares of Lipocine (NASDAQ:LPCN – Free Report) in a report published on Monday. The firm issued a sell rating on the specialty pharmaceutical company’s stock. Lipocine Stock Performance Shares of NASDAQ LPCN opened at $2.41 on Monday. Lipocine has a 52 week low of $2.31 and a 52 week high of […]